Adial Pharmaceuticals, Inc.
General ticker "ADIL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $7.5M (TTM average)
Adial Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -24.3%.
Estimated limits based on current volatility of 3.2%: low 0.30$, high 0.32$
Factors to consider:
- Total employees count: 7 (0.0%) as of 2024
- Top business risk factors: Net losses, Financing risks, Control risks, Economic downturns and volatility, Operational and conduct risks
- Current price 51.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.67$, 2.09$]
- 2025-12-31 to 2026-12-31 estimated range: [0.56$, 1.76$]
Financial Metrics affecting the ADIL estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -35.58 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term ADIL quotes
Long-term ADIL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $10.86MM | $6.89MM | $8.28MM |
| Operating Income | $-10.86MM | $-6.89MM | $-8.28MM |
| Non-Operating Income | $0.06MM | $-0.11MM | $-4.91MM |
| R&D Expense | $1.95MM | $1.27MM | $3.23MM |
| Income(Loss) | $-10.80MM | $-7.00MM | $-13.20MM |
| Other Income(Loss) | $-1.94MM | $1.88MM | $0.00MM |
| Profit(Loss)* | $-14.67MM | $-5.12MM | $-13.20MM |
| Stockholders Equity | $3.28MM | $4.08MM | $4.07MM |
| Assets | $5.73MM | $4.74MM | $5.04MM |
| Operating Cash Flow | $-11.19MM | $-6.81MM | $-6.92MM |
| Capital expenditure | $0.00MM | $6.81MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $1.50MM | $0.00MM |
| Financing Cash Flow | $9.13MM | $4.13MM | $7.85MM |
| Earnings Per Share** | $-13.80 | $-3.60 | $-0.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.